BAJAJ FINSERV DIRECT LIMITED
Latest IPO Information

Sai Life Sciences Ltd. IPO

IPO Date: Dec 11 to Dec 13 2024

Listing Date: Dec 18 2024

Objective

1. Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by our Company; and
2. General corporate purposes.

IPO Details

Face Value ₹ 1.00 Per Share
Issue Size ₹ 2026.92 - 2131.76 Cr
Price Band ₹ 522.00 - ₹ 549.00 Per Share
Market LOT 27 shares
Issue Type Book building

About Company

We are an innovator-focused, contract research, development, and manufacturing organization (“CRDMO”). We provide end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (“NCE”), to global pharmaceutical innovator companies and biotechnology firms. We possess both (a) discovery / contract research (“CRO”) and (b) chemistry, manufacturing, and control (“CMC”) / contract development and manufacturing organization (“CDMO”) capabilities. We are the fastest-growing Indian CRDMOs among listed Indian peers in terms of revenue .... CAGR as well as EBITDA CAGR from Financial Year 2022 to Financial Year 2024. (Source: F&S Report) Our CRDMO platform provides multiple entry points for us to acquire customers in the intermediate stages of their new drug discovery to commercialization journey. We are also one of the few CRDMOs to have a unique delivery model of having research laboratories for discovery and development located near overseas innovation hubs at Watertown (Greater Boston, MA), United States (“US”) and Manchester, United Kingdom (“UK”), complemented by large-scale research laboratories and manufacturing facilities in cost competitive locations in India. (Source: F&S Report) During the Financial Year 2024, we served more than 280 innovator pharmaceutical companies, including 18 of the top 25 pharmaceutical companies (in terms of revenue for the calendar year 2023), across regulated markets, including the US, the UK, Europe and Japan. (Source: F&S Report) During the Financial Year 2024, we also provided CRO services to more than 60 customers on an ongoing basis, for their integrated drug discovery programs. As of March 31, 2024, our CDMO product portfolio included more than 150 innovator pharmaceutical products, including 38 products that were supplied for manufacturing of 28 commercial drugs. Read More
Address

Plot No. D S-7, I K P Knowledge Park Turkapally Village, Shameerpet Mandal Medchal- Malkajgiri District

City

Hyderabad

State

Telangana

Pincode

500078

Phone

040-68156000

Email

info@sailife.com

Website

www.sailife.com

About IPO

Listed At BSE/NSE
Lead Manager Morgan Stanley India Co Pvt Ltd
Promoters
Kanumuri Ranga Raju
Krishnam Raju Kanumuri
Kanumuri Mytreyi
Sai Quest Syn Pvt Ltd.
Marigold Partners
Sunflower Partners
Tulip Partners and Lily Partners

Promoter's Holding

Registrar

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

040 - 67162222/18003094001
einward.ris@kfintech.com
www.kfintech.com

Latest News

Aug
31
2026
COMMODITY Posted on Aug 31st 2026

Govt to allocate fortnightly sale quota to sugar mills from September to prevent artificial scarcity

The government said that retail prices of sugar have started to ease with ex-mill rates declining by around 20 per cent in the last few days and highlighted that it will allocate a fortnightly sale quota to mills from September to ensure smooth supply and prevent artificial scarcity. At present, the food ministry allocates a monthly quota to mills for the sale of sugar. The Food Ministry said it is closely monitoring availability and prices of sugar, while asserting that there is no shortage of sweetener in India.

The ministry said it carried out physical verification of stocks in sugar mills and the exercise revealed that some mills were holding more stocks than declared in monthly returns, while some mills sold less stock than their monthly allocations. To address this problem, the government has decided to introduce a fortnightly sugar allocation system from September, replacing the existing monthly quota system.

Under the fortnightly quota, mills will have to sell at least 40 per cent of the allocation in the first week and the remaining quantity in the succeeding week. Commenting on the benefits of the new measure, the ministry said it will help to monitor the demand and supply situation, respond quickly to changes in market conditions and prevent artificial scarcity. It can release additional stocks if required to maintain adequate market availability. It noted that sugar mills have already been directed to ensure that sugar sold is dispatched from the mill within seven days of sale.

These two measures - fortnightly quota allocation and mandatory dispatch within seven days - would significantly improve the entire supply chain. Bulk consumers of sugar have been asked not to hold stocks in excess of their operational requirements.

Talking about the prevailing high sugar prices, the government said it has taken a series of proactive measures to ensure adequate availability of sugar and prevent artificial tightening of supplies in the domestic market. To control prices, the Centre has recently allowed imports of 10 lakh tonnes of raw sugar by October 31. It has imposed stock holding limits on dealers, as well as bulk consumers like beverage makers. Exports were already banned a few months back. As a result, the ex-mill sugar prices have declined by around 20 per cent in recent days, while retail sugar prices have also started coming down.

Read More
Aug
31
2026
EQUITY Posted on Aug 31st 2026

Power Mech Projects informs about retirement of independent director

Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Power Mech Projects has informed that Vivek Paranjpe (DIN: 03378566), Non-Executive and Independent Director of the Company, completes his second and final term as an Independent Director at the close of business hours on August 30, 2026. Consequently, he will cease to be a Director of the Company. The Board of Directors places on record its deep appreciation for the valuable contributions, effective participation, and immense guidance provided by Vivek Paranjpe during his tenure on the Board, as well as for his dedicated service as a Chiarman of the Nomination and Remuneration Committee, and member of Audit Committee. The details required under Regulation 30 of the SEBI Listing Regulations, read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, are enclosed. 

The above information is a part of company’s filings submitted to BSE.

Read More
Aug
31
2026
EQUITY Posted on Aug 31st 2026

Hero MotoCorp informs about appointment of chief digital & information officer

Pursuant to Regulation 30 of the Listing Regulations, Hero MotoCorp has informed that Suresh Kumar P has been appointed as the Chief Digital & Information Officer of the company with effect from Monday, August 31, 2026. The relevant details of the above said appointment as required under Regulation 30 of the Listing Regulations are attached as Annexure A.
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
31
2026
EQUITY Posted on Aug 31st 2026

Varun Beverages informs about update

In continuation to its earlier disclosure dated August 25, 2026 wherein the company informed that the Board of Directors of the Company had approved the incorporation of a wholly-owned subsidiary company in India, Varun Beverages has informed that ‘KIVA Spirits and Company’ a wholly-owned subsidiary of the Company has been incorporated. (the above information was received today at 9:02 A.M. IST). The detailed disclosure as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/ 14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 had already been submitted in its earlier intimation dated August 25, 2026.

The above information is a part of company’s filings submitted to BSE.

Read More
Aug
31
2026
EQUITY Posted on Aug 31st 2026

Vishal Bearings informs about newspaper advertisements

Pursuant to Regulation 30 read with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and all other applicable regulations, if any, Vishal Bearings has informed that it enclosed the copies of the newspaper advertisements published in Financial Express (English edition) and Financial Express (Gujarati edition) for the attention of the Shareholders regarding 35th Annual General Meeting scheduled to be held on Saturday, September 19, 2026 at 11:00 AM IST through video conference (‘VC’)/Other Audio Video Visual Means. 

The above information is a part of company’s filings submitted to BSE.

Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the issue size of Sai Life Sciences Ltd. IPO?

The issue size of Sai Life Sciences Ltd. IPO is ₹2026.92 - 2131.76 crore.

The Sai Life Sciences Ltd. IPO opens for subscription on 2024-12-11 and closes on 2024-12-13.

The price range of Sai Life Sciences Ltd. IPO is ₹522.00 to ₹549.00.

The lot size of Sai Life Sciences Ltd. IPO is 27 shares.

The registrar of Sai Life Sciences Ltd. IPO is K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.).

Sai Life Sciences Ltd. IPO will be listed on BSE/NSE .

You will typically receive a confirmation message or notification from your broker or trading platform shortly after placing your IPO order. This confirms that your application has been submitted successfully. You can also check the order status in the IPO section of your trading account or app.

Apply early with valid UPI and PAN before 2024-12-13 to increase your chances.

The listing date of Sai Life Sciences Ltd. IPO is 2024-12-18.

An Initial Public Offering (IPO) is when a private company sells shares to the public for the first time, enabling investors to purchase these shares and gain partial ownership in the business. For instance, if a well-known tech firm wants to grow and requires additional funds, it might choose to go public through an IPO. During this process, investors can buy shares, and the company’s stock starts trading on the stock exchange on the day of the IPO listing.

Investors can apply for an IPO through their bank or brokerage account. Many trading platforms have a specific section for IPOs where users can submit their applications online.

The primary market is where shares are offered to the public for the first time via an IPO. After the IPO, shares are traded on the secondary market (stock exchange), where existing shareholders can sell to new buyers.

Investing in an IPO offers the opportunity to become an early investor in companies with high growth potential, at a price which may be lower than their post-listing market value. It provides a chance to participate in the company's growth journey from its early stages. However, IPO investments also come with inherent risks, such as market volatility and uncertainties about the company's future performance.

The price of an IPO is established through a systematic process known as "book building." In this method, investors bid within a given price range, and the final price is set based on demand and market conditions. Several factors play a crucial role in determining the IPO price, including:

Past Financial Performance: Evaluating the company's revenue, profits, and financial stability over time

Growth Potential: Assessing future prospects based on the company's business model and market opportunities

Industry Peers: Comparing valuation metrics with similar companies in the same sector

Larger Industry Picture: Analysing overall industry trends and economic conditions that could impact the company's performance

The lock-in period for IPO shares refers to a duration during which specific investors are restricted from selling their shares post-listing. This period varies based on the type of investor:

Promoters: The lock-in period for promoters ranges from 6 months to 18 months, ensuring their commitment to the company's long-term growth

Anchor Investors: Typically, anchor investors face a shorter lock-in period of 30 to 90 days, depending on regulatory norms and the specific IPO

IPOs can be volatile and may not perform as expected in the short term. Investors risk losing capital if the stock price drops after listing, especially if the company does not meet its growth projections.

Information on upcoming IPOs is often available through brokerage platforms, financial news sites, and regulatory bodies like SEBI, which publishes details on companies going public. You can also get these details under the upcoming IPO section on Bajaj Markets.

Eligibility for an IPO typically includes:

Retail Investors: Individuals who invest in smaller amounts, usually under the “retail investor” category, with certain limits

Qualified Institutional Buyers (QIBs): Entities like mutual funds, banks, and insurance companies, who invest large sums

Non-Institutional Investors (NIIs): High-net-worth individuals or entities investing above the retail threshold

Investors must have a Demat and trading account to apply, and in some cases, certain financial or residency qualifications may apply depending on local regulations.

SME (Small and Medium Enterprise) IPOs generally carry higher risk but may provide significant growth potential. Investors should research the company’s stability, financials, and sector risks, as SME stocks can be more volatile compared to large-cap companies.

View More

Invalid Mobile Number

Invalid Full Name

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore